Data / Form D filings / NBO Pharma Inc.
NBO Pharma Inc.: Form D filing
NBO Pharma Inc., a pharmaceuticals company in Bedford, NY, filed a Form D with the SEC in 2026. The latest, on January 22, 2026, reports $7.6 million sold of a $7.6 million offering to 93 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 64 QUARRY LANE, Bedford, NY, 10506
- Phone
- (914) 645-1130
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 2103906
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 22, 2026 | New notice | $7,640,217 | $7,640,217 | 93 | Jun 12, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Fredric David Price | Executive Officer, Director | |
| Robert Friedman | Director | |
| Colin Foster | Director | |
| Bard Geesaman | Director |
Other pharmaceuticals companies in New York that filed recently
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Jan 19, 2026 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what NBO Pharma Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.